Use of Steroids in Diagnostic Confusion between Intestinal Tuberculosis and Crohn's Disease: A Brief Experience

Abstract

Background Differentiating intestinal tuberculosis (TB) from Crohn's disease (CD) is challenging. Even after complete workup, the underlying diagnosis can often remain unclear. Traditionally, trial of antitubercular therapy (ATT) is resorted to in such situations, but the use of ATT could increase stricturing complications in CD.

Methods We report findings from our cohort of patients with ileocecal ulcers. Among patients with a diagnostic confusion between intestinal TB and CD, steroids were started in an in-hospital setting under close observation. We report a brief series of patients with a close overlap in terms of disease presentation, behavior, laboratory, and histopathological findings. All the cases had skip lesions in the colon with inconclusive final diagnosis. We attempted to differentiate between the two by a short trial of steroids for 2 weeks.

Results Of the 30 patients with ileocecal ulceration, the diagnosis remained uncertain between intestinal TB and CD in three patients. All three patients received steroids for 2 weeks. Eventually, all were diagnosed to have TB. Administration of steroids helped increase microbiological yield with all three having a positive microbiological diagnosis at 2 weeks. However, one patient developed dissemination (pulmonary lesions).

Conclusion With a definitive risk of flare of TB with steroid, we encountered a positive diagnosis with repeat colonoscopy biopsy, positive result in bronchoalveolar lavage, and in third case positive report of cartridge-based nucleotide acid amplification test on repeat colonoscopy biopsy. In cases where differentiation of ileocecal TB from CD is not possible confidently, using a steroid-first approach increases the microbiological yield with a potential risk of dissemination.

Keywords

Crohn's disease - tuberculosis - antitubercular therapy - inflammatory bowel disease - intestinal tuberculosis

Ethical Statement

Written informed consent was obtained from the patients. No ethical approval was sought because the work is a retrospective case series.

Author Contributions

M.K.P. conceptualized, designed, wrote, and edited the final version of manuscript. C.K. was involved in collection of the data and images, follow-up of patients, and writing the manuscript.

Data Availability Statement

All associated data are provided in the manuscript.

Publikationsverlauf

Eingereicht: 18. Januar 2022

Angenommen: 05. Februar 2022

Artikel online veröffentlicht:
22. September 2023

• References

• 1 Morgagni GB. Founders of modern medicine: Giovanni Battista Morgagni. (1682-1771). Med Library Hist J 1903; 1 (04) 270-277
• 2 Ooi CJ, Makharia GK, Hilmi I. et al; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia-Pacific consensus statements on Crohn's disease. Part 2: management. J Gastroenterol Hepatol 2016; 31 (01) 56-68
• 3 Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109 (02) 205-217
• 4 Arnold C, Moradpour D, Blum HE. Tuberculous colitis mimicking Crohn's disease. Am J Gastroenterol 1998; 93 (11) 2294-2296
• 5 Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009; 104 (04) 1003-1012
• 6 Seo H, Lee S, So H. et al. Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis. World J Gastroenterol 2017; 23 (34) 6306-6314
• 7 Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 2007; 25 (12) 1373-1388
• 8 Patel N, Amarapurkar D, Agal S. et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol 2004; 19 (11) 1240-1246
• 9 Sharma V. Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis. Expert Rev Gastroenterol Hepatol 2020; 14 (08) 647-650
• 10 Pratap Mouli V, Munot K, Ananthakrishnan A. et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther 2017; 45 (01) 27-36
• 11 Sharma V, Mandavdhare HS, Dutta U. Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it?. Aliment Pharmacol Ther 2018; 47 (06) 859-860
• 12 Gupta A, Pratap Mouli V, Mohta S. et al. Antitubercular therapy given to differentiate Crohn's disease from intestinal tuberculosis predisposes to stricture formation. J Crohn's Colitis 2020; 14 (11) 1611-1618
• 13 Schuetz P, Christ-Crain M, Schild U. et al. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med 2008; 8 (01) 1
• 14 Soni H, Bellam BL, Rao RK. et al. Use of steroids for abdominal tuberculosis: a systematic review and meta-analysis. Infection 2019; 47 (03) 387-394